AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (September 3, 2004). doi:10.1152/ajplung.00273.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/L610    most recent
00273.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hite, R. D.
Right arrow Articles by Bass, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hite, R. D.
Right arrow Articles by Bass, D. A.
Submitted on July 19, 2004
Accepted on August 30, 2004

Surfactant Phospholipid changes after Antigen Challenge: A Role for Phosphatidylyglycerol in Dysfunction

R. Duncan Hite1*, Michael C. Seeds2, David L. Bowton1, Bonnie L. Grier1, Anca M. Safta1, Rajesh Balkrishnan3, B. Moseley Waite4, and David A. Bass5

1 Department of internal Medicine/Pulmonary and Critical Care Medicine, Wake Forest University Schooll of Medicine, Winston-Salem, NC, USA
2 Department of internal Medicine/Pulmonary and Critical Care Medicine, Wake Forest University Schooll of Medicine, Winston-Salem, NC, USA; Department of Internal Medicine/Molecular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
3 Department of Publich Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of internal Medicine/Pulmonary and Critical Care Medicine, Wake Forest University Schooll of Medicine, Winston-Salem, NC, USA
4 Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of internal Medicine/Pulmonary and Critical Care Medicine, Wake Forest University Schooll of Medicine, Winston-Salem, NC, USA
5 Department of Internal Medicine/Molecular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of internal Medicine/Pulmonary and Critical Care Medicine, Wake Forest University Schooll of Medicine, Winston-Salem, NC, USA

* To whom correspondence should be addressed. E-mail: dhite{at}wfubmc.edu.

In asthma, inflammation-mediated surfactant dysfunction contributes to increased airway resistance, but the mechanisms for dysfunction are not understood. To test mechanisms that alter surfactant function, atopic asthmatics underwent endobronchial antigen challenge and bronchoalveolar lavage (BAL). BAL fluids were sequentially separated into cells, surfactant and supernatant and multiple endpoints were analyzed. Each endpoint's unique relationship to surfactant dysfunction was determined. Our results demonstrate that minimum surface tension ({gamma}min) of surfactant after antigen challenge was significantly increased with a spectrum of responses that included dysfunction in 6 of 13 asthmatics. Antigen challenge significantly altered the partitioning of surfactant phospholipid measured as a decreased ratio of large surfactant aggregates (LA) to small surfactant aggregates (SA), LA/SA ratio. Phosphatidylglycerol (PG) was significantly reduced in the LA of the dysfunctional asthmatic BALs. There was a corresponding significant increase in the ratio of phosphatidylcholine (PC) to PG, which strongly correlated with both increased {gamma}min and decreased LA/SA. Altered surfactant phospholipid properties correlated with surfactant dysfunction as well or better than either increased eosinophils or protein. Secretory phospholipase activity, measured in vitro, increased after antigen challenge and may explain the decrease in surfactant PG. In summary, alteration of phospholipids, particularly depletion of PG, in the LA of surfactant may be an important mechanism in asthma-associated surfactant dysfunction.




This article has been cited by other articles:


Home page
Eur Respir JHome page
E. D. Fixman, A. Stewart, and J. G. Martin
Basic mechanisms of development of airway structural changes in asthma
Eur. Respir. J., February 1, 2007; 29(2): 379 - 389.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
K. Rodriguez-Capote, D. Manzanares, T. Haines, and F. Possmayer
Reactive Oxygen Species Inactivation of Surfactant Involves Structural and Functional Alterations to Surfactant Proteins SP-B and SP-C
Biophys. J., April 15, 2006; 90(8): 2808 - 2821.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. G. Cochrane
Pulmonary surfactant in allergic inflammation: new insights into the molecular mechanisms of surfactant function
Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L608 - L609.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.